switched from 12.5mg to 0.5mg and the fatigue got better, not worse
Trying to settle this properly because the thread from last year went in circles.
The claim: compounding matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 10 months without either producing anything.
What would actually settle it is 3 people measuring the same thing the same way. I have started; my numbers are below. They lean one way but not strongly enough for me to declare victory.
If you have data, post the data. If you have an opinion, flair it as an opinion.
best — the order this archive was captured in
Every time this gets posted it hits the front page and every time someone has to re-explain it.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Tracking number removed. It identifies both ends of a shipment.
the 503A/503B distinction is load-bearing, do not blur it
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
Asked 5 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
Yeah, 503A and 503B are different regulatory animals.